Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease.
Hsueh
W
W
D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D016564:Amyloid beta-Protein Precursor / Q000235:genetics* / Q000378:metabolism; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics* / Q000378:metabolism; D048909:Diabetes Complications; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000502:physiology; D007333:Insulin Resistance; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
D016564:Amyloid beta-Protein Precursor; D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D000077154:Rosiglitazone